These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Choroid vascular occlusion and ischemic optic neuropathy after facial calcium hydroxyapatite injection- a case report. Chou CC; Chen HH; Tsai YY; Li YL; Lin HJ BMC Surg; 2015 Mar; 15():21. PubMed ID: 25884651 [TBL] [Abstract][Full Text] [Related]
5. A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment. Cassuto D; Sundaram H Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):48S-58S. PubMed ID: 24077011 [TBL] [Abstract][Full Text] [Related]
6. Management of impending necrosis associated with soft tissue filler injections. Dayan SH; Arkins JP; Mathison CC J Drugs Dermatol; 2011 Sep; 10(9):1007-12. PubMed ID: 22052269 [TBL] [Abstract][Full Text] [Related]
7. Subperiosteal injections during facial soft tissue filler injections-Is it possible? Pavicic T; Yankova M; Schenck TL; Frank K; Freytag DL; Sykes J; Green JB; Hamade H; Casabona G; Cotofana S J Cosmet Dermatol; 2020 Mar; 19(3):590-595. PubMed ID: 31310047 [TBL] [Abstract][Full Text] [Related]
8. Eyelid mass secondary to injection of calcium hydroxylapatite facial filler. Lee MJ; Sung MS; Kim NJ; Choung HK; Khwarg SI Ophthalmic Plast Reconstr Surg; 2008; 24(5):421-3. PubMed ID: 18806674 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Jansen DA; Graivier MH Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541 [TBL] [Abstract][Full Text] [Related]
10. Generation of Filler Emboli as a Mechanism for Filler-Related Blindness. Ugradar S; Diniz S; Hoenig J; Goldberg RA Dermatol Surg; 2021 Feb; 47(2):235-237. PubMed ID: 33273358 [TBL] [Abstract][Full Text] [Related]
11. Light Perception Vision Recovery After Treatment for Calcium Hydroxylapatite Cosmetic Filler-Induced Blindness. Vu PQ; Grob SR; Tao JP Ophthalmic Plast Reconstr Surg; 2018; 34(6):e189-e192. PubMed ID: 30234833 [TBL] [Abstract][Full Text] [Related]
12. Calcium hydroxylapatite associated soft tissue necrosis: a case report and treatment guideline. Tracy L; Ridgway J; Nelson JS; Lowe N; Wong B J Plast Reconstr Aesthet Surg; 2014 Apr; 67(4):564-8. PubMed ID: 23993752 [TBL] [Abstract][Full Text] [Related]
13. Visual loss following cosmetic facial filler injection. Shoughy SS Arq Bras Oftalmol; 2019; 82(6):511-513. PubMed ID: 31531542 [TBL] [Abstract][Full Text] [Related]
14. Ocular complications of soft tissue filler injections: A review of literature. Lee W; Koh IS; Oh W; Yang EJ J Cosmet Dermatol; 2020 Apr; 19(4):772-781. PubMed ID: 31709739 [TBL] [Abstract][Full Text] [Related]
15. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. Daines SM; Williams EF JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246 [TBL] [Abstract][Full Text] [Related]
16. Calcium hydroxylapatite filler: an overview of safety and tolerability. Pavicic T J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146 [TBL] [Abstract][Full Text] [Related]
17. Alterations in Nasal Sensibility Following Calcium Hydroxyapatite Dorsal Augmentation. Alharethy S J Craniofac Surg; 2018 Mar; 29(2):e104-e106. PubMed ID: 29068971 [TBL] [Abstract][Full Text] [Related]
18. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events. Van Loghem JAJ J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225 [TBL] [Abstract][Full Text] [Related]
19. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions. Alam M; Yoo SS J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371 [TBL] [Abstract][Full Text] [Related]